Turtle Cameron
Spyre Therapeutics, Inc. · Chief Executive Officer
Turtle Cameron is listed in filings as Chief Executive Officer at Spyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Spyre Therapeutics, Inc. (SYRE) and Damora Therapeutics, Inc. (DMRA). The current snapshot covers public activity from Dec 3, 2025 to Jun 3, 2026. Reported amounts are shown as $119.5K to $3.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $119k4k shares | SellDec 1, 2025 | $29.83 | $102.70 | |
| $316k11k shares | SellDec 1, 2025 | $28.73 | $102.70 | |
| $3.2k100 shares | SellJan 2, 2026 | $32.39 | $102.70 | |
| $70k2.2k shares | SellJan 2, 2026 | $31.79 | $102.70 | |
| $387k12.7k shares | SellJan 2, 2026 | $30.47 | $102.70 | |
| $607k12.3k shares | SellApr 1, 2026 | $49.20 | $102.70 |